Evidence map›Paper›PMID 37810369›Full record

ReviewAcupuncture and herbal medicine2023

Expert consensus on the use of traditional Chinese medicine for the treatment of common symptoms of post-COVID-19 short-term condition.

Junhua Zhang, Bo Pang, Qingquan Liu, Hongchun Zhang, Wenke Zheng, Fengwen Yang, Wentai Pang, Xinyao Jin, Enxiang Chao, Boli Zhang

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Acupuncture and herbal medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Junhua ZhangTianjin University of Traditional Chinese Medicine, Tianjin, China.
Bo PangTianjin University of Traditional Chinese Medicine, Tianjin, China.
Qingquan LiuBeijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
Hongchun ZhangChina-Japan Friendship Hospital, Beijing, China.
Wenke ZhengTianjin University of Traditional Chinese Medicine, Tianjin, China.
Fengwen YangTianjin University of Traditional Chinese Medicine, Tianjin, China.
Wentai PangTianjin University of Traditional Chinese Medicine, Tianjin, China.
Xinyao JinTianjin University of Traditional Chinese Medicine, Tianjin, China.
Enxiang ChaoChina-Japan Friendship Hospital, Beijing, China.
Boli ZhangTianjin University of Traditional Chinese Medicine, Tianjin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A proportion of patients who recovered from COVID-19 have ongoing, recurrent, or new symptoms with negative nucleic acid/antigen test results, which has become a new public health problem that needs to be concerned. Traditional Chinese medicine (TCM) has shown its unique advantages in preventing, treating, and rehabilitating COVID-19. To further standardize clinician's clinical diagnosis and use of TCM for the treatment of common symptoms associated with COVID-19 infection following negative nucleic acid/antigen results, the front-line clinical experts were invited for discussion on the concepts, etiology, clinical manifestations of post-COVID-19 condition, and on treatment with TCM to form the consensus. Clinicians of TCM, Western medicine, or integration of both can use this consensus document for clinical practice and research purposes.

Indexed as

Expert consensusPost-COVID-19 short-term conditionTraditional Chinese medicine

Identifiers

PMID37810369
PMCPMC10317190

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.